Estramustine resistance correlates with tau over-expression in human prostatic carcinoma cells

International Journal of Cancer

Volumn 77, Issue 4, 1998, Pages 626-631

  Sangrajrang, Suleeporn ^a,d   Denoulet, Philippe ^b   Millot, Guy ^a   Tatoud, Roger ^a   Podgorniak, Marie Pierre ^a   Tew, Kenneth D ^c   Calvo, Fabien ^a   Fellous, Arlette ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b PSL Research University   (France)

^c FOX CHASE CANCER CENTER   (United States)

^d IGM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRAMUSTINE; TAU PROTEIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DEPOLYMERIZATION; DOSE RESPONSE; DRUG EFFECT; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; MICROTUBULE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN PHOSPHORYLATION; RNA TRANSLATION;

EID: 0031823710     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980812)77:4<626::AID-IJC24>3.0.CO;2-2     Document Type: Article

References (23)

1. 262 strongly reduces binding of tau to microtubules: distribution between PHF-like immunoreactivity and microtubule binding. Neuron, 11, 153-163 (1993).
2. BOUCHER, D., LARCHER, J.C., GROS, F. and DENOULET, P., Polyglutamylation of tubulin as a progressive regulator of in vitro interactions between the microtubule-associated protein tau and tubulin. Biochemistry, 33, 12471-12477 (1994).
3. DAHLLÖF, B., BILLSTRÖM, A., CABRAL, F. and HARTLEY-ASP, B., Estramus- tine depolymerizes microtubules by binding to tubulin. Cancer Res., 53, 4573-4581 (1993).
4. DREWES, G., LICHTENBERG-KRAAG, B., DORING, F., MANDELKOW, E.M., BIERNAT, J., GORIS, J., DOREE, M. and MANDELKOW, E., Mitogen activated protein (MAP) kinase tranforms tau protein into an Alzheimer-like state. EMBO J., 11, 2131-2138 (1992).
5. DRUBIN, D.G. and KIRSCHNER, M.W., Tau protein function in living cells. J. Cell. Biol., 103, 2739-2746 (1986).
6. GARCIA DE ANCOS, J., CORREAS, I. and AVILA, J., Differences in microtubule binding and self-association ability of bovine brain tau isofonns. J. Biol. Chem., 268, 7976-7982 (1993).
7. GOEDERT, M., SPILLANTINI, M.G., CAIRNS, N.J. and CROWTHER, R.A., Tau protein of Alzheimer paired helical filament: abnormal phosphorylation of all six brain isoforms. Neuron, 8, 159-168 (1992).
8. GOEDERT, M., SPILLANTINI, M.G., JAKES, R., RUTHERFORD, D. and CROWTHER, R.A., Multiple isoforms of human microtubule-associated protein tau: sequences and location in neurofibrillary tangles of Alzheimer's disease. Neuron, 3, 519-526 (1989).
9. GU, Y., OYAMA, F. and IHARA. Y., Tau is widely expressed in rat tissues. J. Neurochem., 67, 1235-1244 (1996).
10. KOSIK, K.S., ORECCHINO, L.D., BAKALIS, S. and NEVE, R.L., Developmentally regulated expression of specific tau sequences. Neuron. 2, 1389-1397 (1989).
11. LAING, N., DAHLLÖF, B., HARTLEY-ASP, B., RANGANATHAN, S. and TEW, K.D., The interaction of estramustine with tubulin isotypes. Biochemistry, 36, 871-878 (1997).
12. LEE, G. and ROOK, S.L., Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. J. Cell Sci., 102, 227-237 (1992).
13. LOVERSTONE, S., HARTLEY, C.L., PEARCE, J. and ANDERTON, B.H., Phosphorylation of tau by glycogen synthase kinase-3 beta in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience, 73, 1145-1157 (1996).
14. MORAGA, D., RIVAS-BERRIOS, A., FARIAS, G., WALLIN, M. and MACCIONI, R.B., Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and tau. Biochim. biophys. Acta, 1121, 97-103 (1992).
15. NUNEZ, J., Differential expression of microtubule components during brain development. Develop. Neurosci., 8, 125-141 (1986).
16. PANDA, D., MILLER, H.P., ISLAM, K. and WILSON, L., Stabilization of microtubule dynamics by estramustine by binding to a novel site on tubulin: a possible mechanistic basis for antitumor action. Proc. nat. Acad. Sci. (Wash.), 94, 10560-10564 (1997).
17. SANGRAJRANG, S., DENOULET, P., LAING, N.M., TATOUD, R., MILLOT, M., CALVO, F., TEW, K.D. and FELLOUS, A., Association of estramustine resistance in human prostatic carcinoma cells with modified patterns of tubulin expression. Biochem. Pharmacol., 55, 325-331 (1998).
18. SPEICHER, L.A., BARONE, L. and TEW, K.D., Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. Cancer Res., 52, 4433-4440 (1992).
19. SPEICHER, L.A., SHERIDEN, V.R., GODWIN, A.K. and TEW, K.D., Resistance to the antimitotic drug estramustine is distinct from the multidrug resistant phenotype. Brit. J. Cancer, 64, 267-273 (1991).
20. TRINCZEK, B., BIERNAT, J., BAUMANN, K., MANDELKOW, E.M. and MANDELKOW, E., Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules. Mol. biol. Cell, 6, 1887-1902 (1995).
21. VANTARD, M., SCHELLENBAUM, P., FELLOUS, A. and LAMBERT, A.M., Characterization of maize microtubule-associated proteins, one of which is immunologically related to tau. Biochemistry, 30, 9334-9340 (1991).
22. WATANABE, A., HASEGAWA, M., SUZUKI, M., TAKIO, K., MORISHIMA-KAWASHIWA, M., TITANI, K., ARAI T., KPSIK, K. and IHARA, Y., In vivo phosphorylation sites in fetal and adult rat tau. J. biol. Chem., 34. 25721-25717 (1993).
23. WEINGARTEN, M.D., LOCKWOOD, A.H., HWO, S.Y. and KIRSCHNER, M.W., A protein factor essential for microtubule assembly. Proc. nat.. Acad. Sci. (Wash.), 72, 1858-1862 (1975).